C
China Resources Double-Crane Pharmaceutical Co Ltd
SSE:600062
China Resources Double-Crane Pharmaceutical Co Ltd
SSE:600062
Price:
18.62
CNY
-0.27%
Market Closed
Market Cap:
¥19.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
China Resources Double-Crane Pharmaceutical Co Ltd
SSE:600062
|
CN |
|
Eden Research PLC
LSE:EDEN
|
UK |
Balance Sheet
Balance Sheet Decomposition
China Resources Double-Crane Pharmaceutical Co Ltd
China Resources Double-Crane Pharmaceutical Co Ltd
Balance Sheet Decomposition is not available for
China Resources Double-Crane Pharmaceutical Co Ltd
China Resources Double-Crane Pharmaceutical Co Ltd
Balance Sheet
China Resources Double-Crane Pharmaceutical Co Ltd
China Resources Double-Crane Pharmaceutical Co Ltd
Currency: CNY
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
555
|
514
|
445
|
574
|
669
|
468
|
654
|
1 028
|
1 024
|
1 057
|
1 105
|
1 005
|
1 410
|
1 373
|
778
|
1 487
|
1 247
|
1 090
|
1 838
|
2 410
|
2 819
|
2 615
|
3 203
|
2 838
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2 819
|
2 615
|
3 203
|
2 838
|
|
| Cash Equivalents |
555
|
514
|
445
|
574
|
669
|
468
|
654
|
1 028
|
1 024
|
1 057
|
1 105
|
1 004
|
1 409
|
1 373
|
778
|
1 487
|
1 247
|
1 090
|
1 838
|
2 410
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
500
|
409
|
150
|
645
|
1 009
|
858
|
852
|
804
|
200
|
241
|
0
|
|
| Total Receivables |
620
|
968
|
1 244
|
987
|
842
|
734
|
982
|
791
|
1 087
|
1 237
|
1 633
|
1 812
|
1 744
|
1 648
|
1 663
|
1 822
|
1 829
|
1 931
|
2 054
|
2 137
|
2 044
|
2 681
|
3 997
|
2 808
|
|
| Accounts Receivables |
542
|
824
|
1 038
|
814
|
594
|
507
|
500
|
535
|
573
|
663
|
962
|
887
|
615
|
806
|
897
|
894
|
956
|
1 066
|
1 189
|
1 186
|
1 233
|
1 343
|
1 729
|
1 765
|
|
| Other Receivables |
78
|
144
|
206
|
173
|
248
|
227
|
482
|
256
|
514
|
574
|
671
|
925
|
1 129
|
842
|
766
|
928
|
873
|
865
|
865
|
951
|
811
|
1 338
|
2 268
|
1 043
|
|
| Inventory |
407
|
585
|
564
|
485
|
507
|
470
|
529
|
605
|
600
|
727
|
701
|
779
|
566
|
745
|
809
|
763
|
974
|
974
|
1 146
|
1 289
|
1 665
|
1 900
|
1 688
|
1 594
|
|
| Other Current Assets |
94
|
114
|
100
|
93
|
116
|
169
|
146
|
258
|
159
|
234
|
258
|
296
|
111
|
111
|
100
|
84
|
85
|
131
|
142
|
113
|
191
|
242
|
248
|
237
|
|
| Total Current Assets |
1 676
|
2 181
|
2 352
|
2 139
|
2 134
|
1 841
|
2 311
|
2 682
|
2 870
|
3 255
|
3 697
|
3 892
|
3 831
|
4 376
|
3 759
|
4 306
|
4 780
|
5 135
|
6 039
|
6 800
|
7 523
|
7 639
|
9 382
|
7 477
|
|
| PP&E Net |
910
|
1 120
|
1 539
|
1 552
|
1 505
|
1 077
|
998
|
1 224
|
1 433
|
1 603
|
1 827
|
2 028
|
2 068
|
2 393
|
2 541
|
2 420
|
2 475
|
2 643
|
2 639
|
2 691
|
3 016
|
3 622
|
4 096
|
4 340
|
|
| PP&E Gross |
910
|
1 120
|
1 539
|
1 552
|
1 505
|
1 077
|
998
|
1 224
|
1 433
|
1 603
|
1 827
|
2 028
|
2 068
|
2 393
|
2 541
|
2 420
|
2 475
|
2 643
|
2 639
|
2 691
|
3 016
|
3 622
|
4 096
|
4 340
|
|
| Accumulated Depreciation |
365
|
458
|
574
|
511
|
544
|
399
|
487
|
602
|
699
|
840
|
877
|
985
|
1 163
|
1 493
|
1 678
|
1 919
|
2 087
|
2 207
|
2 264
|
2 382
|
2 477
|
2 858
|
3 832
|
4 123
|
|
| Intangible Assets |
45
|
76
|
79
|
75
|
53
|
153
|
164
|
148
|
202
|
233
|
308
|
343
|
385
|
411
|
978
|
1 032
|
1 316
|
1 526
|
1 637
|
1 651
|
1 899
|
2 420
|
2 559
|
2 474
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
9
|
9
|
9
|
67
|
110
|
110
|
125
|
392
|
392
|
797
|
864
|
840
|
796
|
788
|
935
|
908
|
878
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
16
|
8
|
0
|
2
|
|
| Long-Term Investments |
99
|
194
|
326
|
252
|
110
|
191
|
185
|
179
|
175
|
176
|
150
|
109
|
55
|
49
|
52
|
38
|
8
|
74
|
60
|
413
|
343
|
394
|
1 095
|
1 128
|
|
| Other Long-Term Assets |
6
|
45
|
1
|
8
|
11
|
19
|
15
|
27
|
29
|
32
|
28
|
26
|
33
|
50
|
42
|
54
|
62
|
64
|
62
|
65
|
91
|
148
|
163
|
387
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
9
|
9
|
9
|
67
|
110
|
110
|
125
|
392
|
392
|
797
|
864
|
840
|
796
|
788
|
935
|
908
|
878
|
|
| Total Assets |
2 736
N/A
|
3 616
+32%
|
4 296
+19%
|
4 025
-6%
|
3 813
-5%
|
3 281
-14%
|
3 673
+12%
|
4 269
+16%
|
4 717
+10%
|
5 308
+13%
|
6 077
+14%
|
6 508
+7%
|
6 481
0%
|
7 405
+14%
|
7 763
+5%
|
8 242
+6%
|
9 438
+15%
|
10 306
+9%
|
11 277
+9%
|
12 416
+10%
|
13 676
+10%
|
15 165
+11%
|
18 203
+20%
|
16 686
-8%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
424
|
712
|
881
|
746
|
568
|
458
|
390
|
310
|
347
|
369
|
516
|
577
|
429
|
549
|
397
|
396
|
469
|
547
|
684
|
848
|
833
|
731
|
715
|
816
|
|
| Accrued Liabilities |
125
|
214
|
221
|
271
|
201
|
204
|
163
|
205
|
232
|
272
|
322
|
108
|
98
|
127
|
159
|
173
|
219
|
279
|
314
|
291
|
345
|
484
|
1 669
|
673
|
|
| Short-Term Debt |
440
|
769
|
1 032
|
864
|
895
|
490
|
507
|
456
|
449
|
486
|
590
|
678
|
210
|
12
|
3
|
0
|
0
|
40
|
201
|
139
|
19
|
237
|
85
|
118
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
30
|
0
|
0
|
34
|
7
|
0
|
18
|
20
|
223
|
23
|
|
| Other Current Liabilities |
163
|
226
|
147
|
352
|
157
|
96
|
197
|
106
|
101
|
134
|
224
|
320
|
292
|
401
|
515
|
446
|
521
|
1 227
|
1 135
|
1 392
|
1 516
|
1 610
|
2 088
|
2 371
|
|
| Total Current Liabilities |
1 152
|
1 921
|
2 281
|
2 232
|
1 822
|
1 248
|
1 257
|
1 077
|
1 129
|
1 261
|
1 652
|
1 682
|
1 029
|
1 090
|
1 104
|
1 015
|
1 209
|
2 128
|
2 341
|
2 670
|
2 731
|
3 082
|
4 779
|
4 003
|
|
| Long-Term Debt |
52
|
9
|
204
|
4
|
4
|
0
|
0
|
0
|
0
|
13
|
0
|
0
|
0
|
1
|
11
|
0
|
0
|
7
|
0
|
0
|
35
|
233
|
34
|
1 116
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
4
|
3
|
2
|
4
|
0
|
0
|
1
|
79
|
74
|
100
|
111
|
105
|
104
|
120
|
176
|
159
|
124
|
|
| Minority Interest |
203
|
201
|
224
|
189
|
211
|
174
|
167
|
71
|
59
|
64
|
86
|
53
|
3
|
25
|
327
|
352
|
392
|
69
|
74
|
83
|
571
|
768
|
686
|
704
|
|
| Other Liabilities |
54
|
37
|
61
|
61
|
48
|
30
|
50
|
37
|
50
|
73
|
78
|
119
|
116
|
135
|
135
|
114
|
280
|
151
|
154
|
266
|
313
|
349
|
332
|
332
|
|
| Total Liabilities |
1 461
N/A
|
2 168
+48%
|
2 769
+28%
|
2 487
-10%
|
2 085
-16%
|
1 452
-30%
|
1 476
+2%
|
1 189
-19%
|
1 241
+4%
|
1 413
+14%
|
1 819
+29%
|
1 854
+2%
|
1 148
-38%
|
1 252
+9%
|
1 656
+32%
|
1 555
-6%
|
1 981
+27%
|
2 466
+24%
|
2 674
+8%
|
3 122
+17%
|
3 771
+21%
|
4 609
+22%
|
5 989
+30%
|
6 278
+5%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
339
|
441
|
441
|
441
|
441
|
441
|
441
|
476
|
572
|
572
|
572
|
572
|
572
|
572
|
724
|
724
|
869
|
1 043
|
1 043
|
1 043
|
1 043
|
1 043
|
1 040
|
1 039
|
|
| Retained Earnings |
267
|
440
|
489
|
494
|
680
|
780
|
1 147
|
1 439
|
1 737
|
2 123
|
2 521
|
2 916
|
3 602
|
4 232
|
4 721
|
5 301
|
5 927
|
6 650
|
7 416
|
8 104
|
8 722
|
9 421
|
10 469
|
9 280
|
|
| Additional Paid In Capital |
669
|
567
|
597
|
604
|
608
|
609
|
609
|
1 164
|
1 168
|
1 200
|
1 165
|
1 166
|
1 159
|
1 350
|
660
|
660
|
660
|
149
|
149
|
149
|
149
|
275
|
838
|
193
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
176
|
126
|
74
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
3
|
6
|
2
|
9
|
7
|
7
|
30
|
|
| Total Equity |
1 275
N/A
|
1 448
+14%
|
1 527
+5%
|
1 538
+1%
|
1 728
+12%
|
1 830
+6%
|
2 197
+20%
|
3 080
+40%
|
3 476
+13%
|
3 895
+12%
|
4 258
+9%
|
4 654
+9%
|
5 333
+15%
|
6 153
+15%
|
6 107
-1%
|
6 686
+9%
|
7 457
+12%
|
7 840
+5%
|
8 603
+10%
|
9 294
+8%
|
9 905
+7%
|
10 556
+7%
|
12 213
+16%
|
10 408
-15%
|
|
| Total Liabilities & Equity |
2 736
N/A
|
3 616
+32%
|
4 296
+19%
|
4 025
-6%
|
3 813
-5%
|
3 281
-14%
|
3 673
+12%
|
4 269
+16%
|
4 717
+10%
|
5 308
+13%
|
6 077
+14%
|
6 508
+7%
|
6 481
0%
|
7 405
+14%
|
7 763
+5%
|
8 242
+6%
|
9 438
+15%
|
10 306
+9%
|
11 277
+9%
|
12 416
+10%
|
13 676
+10%
|
15 165
+11%
|
18 203
+20%
|
16 686
-8%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
586
|
762
|
762
|
762
|
762
|
762
|
762
|
823
|
823
|
823
|
823
|
823
|
823
|
823
|
1 043
|
1 043
|
1 043
|
1 043
|
1 043
|
1 043
|
1 043
|
1 024
|
1 021
|
1 039
|
|
Switch to:
Switch to:
See Also
Discover More
